No difference in mortality between terlipressin and somatostatin treatments in cirrhotic patients with esophageal variceal bleeding and renal functional impairment

To study the differences in mortality between terlipressin and somatostatin treatments in cirrhotic patients with esophageal variceal bleeding (EVB) and renal functional impairment (RFI). METHODS: The National Health Insurance Database, part of the Taiwan National Health Insurance Program, was used...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Eur J Gastroenterol Hepatol
Main Authors: Hung, Tsung-Hsing, Tsai, Chen-Chi, Tseng, Chih-Wei, Tseng, Kuo-Chih, Hsieh, Yu-Hsi, Tsai, Chih-Chun
Formato: Artigo
Idioma:Inglês
Publicado: Lippincott Williams And Wilkins 2016
Assuntos:
Original Articles: Liver Failure
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5051540/
https://ncbi.nlm.nih.gov/pubmed/27455080
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MEG.0000000000000703
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares